# Tvardi Therapeutics, Inc.: Form 8-K, filed Jan 17, 2025

- Company: [Tvardi Therapeutics, Inc.](/companies/tvrd.md) (CIK 1346830)
- Form: 8-K
- Filed: 2025-01-17
- Accepted by EDGAR: Jan 17, 2025, 16:43 ET
- Period: 2025-01-14
- Accession: 0001104659-25-004517
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1346830/000110465925004517/tm2430195d6_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1346830/000110465925004517/

## Items reported

- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1346830/000110465925004517/tm2430195d6_8k.htm

Filed Jan 17, 2025.
Source: SEC EDGAR, the filing index for accession 0001104659-25-004517. Last ingested by Listed: Oct 24, 2026, 15:11 ET. No prices; not investment advice.